RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Roche Holding Net Income 2024

Roche Holding Net Income

12.59 B CHF

Roche Holding Dividend yield

4.32 %

Ticker

ROG.SW

ISIN

CH0012032048

WKN

855167

In 2024, Roche Holding's profit amounted to 12.59 B CHF, a 9.47% increase from the 11.5 B CHF profit recorded in the previous year.

The Roche Holding Net Income history

YEARNET INCOME (undefined CHF)
2029e16.51
2028e15.7
2027e15.01
2026e14.45
2025e13.78
2024e12.59
202311.5
202212.42
202113.93
202014.3
201913.5
201810.5
20178.63
20169.58
20158.86
20149.33
201311.16
20129.43
20119.34
20108.67
20097.78
20088.97
20079.76
20067.88
20055.92
20046.61

Roche Holding Aktienanalyse

What does Roche Holding do?

Roche Holding AG is a Swiss company that operates in the pharmaceutical and diagnostics sectors. It was founded in Basel in 1896 by Fritz Hoffmann-La Roche and is now one of the largest pharmaceutical companies in the world. The business model of Roche is based on research, development, and distribution of innovative medications and diagnostics for the early detection, diagnosis, and treatment of diseases. Its customers include doctors, hospitals, and laboratories. Roche has three operating divisions: Pharma, Diagnostics, and Genentech. The Pharma division is responsible for the development and marketing of prescription drugs, the Diagnostics division offers a wide range of products for disease diagnosis, and the Genentech division focuses on the development of biotechnological drugs. Roche is known for its strong research investments in new medications and has played a significant role in the history of drug development. The company employs approximately 94,000 people worldwide and is listed on the Swiss stock exchange (SIX: ROG). Some of its well-known products include the cancer drug Avastin, the multiple sclerosis drug Ocrevus, and the diabetes medication RoActemra. Roche is also known for its innovative diagnostic products and has developed numerous tests for disease detection. In recent years, the company has expanded its activities into new therapy areas such as immunotherapy and gene therapy, and it has a strong pipeline of new medications and diagnostics that will be launched in the coming years. Overall, Roche has played a significant role in drug development and diagnostics since its inception, and with its research investments and diverse product portfolio, it will continue to play an important role in the healthcare industry. Roche Holding ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Roche Holding's Profit Margins

The profit margins of Roche Holding represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Roche Holding's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Roche Holding's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Roche Holding's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Roche Holding’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Roche Holding Stock

How much profit has Roche Holding made this year?

Roche Holding has made 12.59 B CHF this year.

How has the profit developed compared to last year?

The profit has increased by 9.47% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Roche Holding publish its earnings?

Roche Holding publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Roche Holding?

The profits of Roche Holding are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Roche Holding?

You can learn more about the earnings of Roche Holding by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Roche Holding pay?

Over the past 12 months, Roche Holding paid a dividend of 9.5 CHF . This corresponds to a dividend yield of about 4.32 %. For the coming 12 months, Roche Holding is expected to pay a dividend of 11.25 CHF.

What is the dividend yield of Roche Holding?

The current dividend yield of Roche Holding is 4.32 %.

When does Roche Holding pay dividends?

Roche Holding pays a quarterly dividend. This is distributed in the months of April, April, April, April.

How secure is the dividend of Roche Holding?

Roche Holding paid dividends every year for the past 37 years.

What is the dividend of Roche Holding?

For the upcoming 12 months, dividends amounting to 11.25 CHF are expected. This corresponds to a dividend yield of 5.11 %.

In which sector is Roche Holding located?

Roche Holding is assigned to the 'Health' sector.

Wann musste ich die Aktien von Roche Holding kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Roche Holding from 3/18/2024 amounting to 9.6 CHF, you needed to have the stock in your portfolio before the ex-date on 3/14/2024.

When did Roche Holding pay the last dividend?

The last dividend was paid out on 3/18/2024.

What was the dividend of Roche Holding in the year 2023?

In the year 2023, Roche Holding distributed 9.3 CHF as dividends.

In which currency does Roche Holding pay out the dividend?

The dividends of Roche Holding are distributed in CHF.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Roche Holding

Our stock analysis for Roche Holding Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Roche Holding Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.